Aesther Healthcare Acquisition Corp (NASDAQ: AEHA) Announces Filing of Preliminary Proxy Statement with SEC in Connection with its Proposed Business Combination with Ocean Biomedical, Inc.
NEW YORK and PROVIDENCE, R.I., Sept. 19, 2022 (GLOBE NEWSWIRE) — Aesther Healthcare Acquisition Corp (NASDAQ:AEHA) (“Aesther”), a special purpose acquisition company (SPAC) and Ocean Biomedical, Inc. (“Ocean”), a next-generation biopharma company announced today that AHEA has filed with the U.S. Securities and Exchange Commission (“SEC”) a preliminary proxy statement (“Preliminary Proxy Statement”) in connection with its proposed business combination (the “Business Combination” or the “Transaction”) with Ocean.